Diagnostic applications of nuclear medicine: Pancreatic cancer
Nuclear Oncology: From Pathophysiology to Clinical Applications, Page: 891-917
2022
- 3Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures3
- Readers3
Book Chapter Description
Pancreatic cancer can be assessed through a variety of imaging techniques including endoscopic ultrasonography (EUS), computed tomography (CT), endoscopic retrograde cholangiopancreatography (ERCP), magnetic resonance imaging (MRI), and magnetic resonance cholangiopancreatography (MRCP). These imaging modalities are often effective in the evaluation of pancreatic cancers, although sometimes they require the additional use of radiopharmaceuticals with positron and single-photon emission CT (PET and SPECT) imaging techniques. In this chapter, the role of nuclear medicine with various radiolabeled compounds and the rationale for their use in endocrine and nonendocrine pancreatic tumors are discussed.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85153827872&origin=inward; http://dx.doi.org/10.1007/978-3-031-05494-5_17; https://link.springer.com/10.1007/978-3-031-05494-5_17; https://dx.doi.org/10.1007/978-3-031-05494-5_17; https://link.springer.com/referenceworkentry/10.1007/978-3-031-05494-5_17
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know